Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages.
Jennifer M RosenbluthRon C J SchackmannG Kenneth GrayLaura M SelforsCarman Man-Chung LiMackenzie BoedickerHendrik J KuikenAndrea RichardsonJane BrockJudy GarberDeborah DillonNorman SachsHans CleversJoan S BruggePublished in: Nature communications (2020)
Recently, organoid technology has been used to generate a large repository of breast cancer organoids. Here we present an extensive evaluation of the ability of organoid culture technology to preserve complex stem/progenitor and differentiated cell types via long-term propagation of normal human mammary tissues. Basal/stem and luminal progenitor cells can differentiate in culture to generate mature basal and luminal cell types, including ER+ cells that have been challenging to maintain in culture. Cells associated with increased cancer risk can also be propagated. Single-cell analyses of matched organoid cultures and native tissues by mass cytometry for 38 markers provide a higher resolution representation of the multiple mammary epithelial cell types in the organoids, and demonstrate that protein expression patterns of the tissue of origin can be preserved in culture. These studies indicate that organoid cultures provide a valuable platform for studies of mammary differentiation, transformation, and breast cancer risk.
Keyphrases
- single cell
- induced apoptosis
- induced pluripotent stem cells
- rna seq
- endothelial cells
- breast cancer risk
- high throughput
- cell cycle arrest
- cell therapy
- endoplasmic reticulum stress
- pluripotent stem cells
- cell death
- case control
- papillary thyroid
- signaling pathway
- bone marrow
- mesenchymal stem cells
- breast cancer cells